bioAffinity Technologies ... (BIAFW)
0.50
-0.00 (-0.30%)
At close: Jan 15, 2025, 12:19 PM
undefined% (undefined)
| Bid | 0.5 |
| Market Cap | 7.82M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.5 |
| Volume | 1,369 |
| Avg. Volume (20D) | 0 |
| Open | 0.50 |
| Previous Close | 0.50 |
| Day's Range | 0.50 - 0.50 |
| 52-Week Range | 0.50 - 0.50 |
| Beta | undefined |
About BIAFW
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX....
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date n/a
Employees 75
Stock Exchange NASDAQ
Ticker Symbol BIAFW
Website http://www.bioaffinitytech.com